These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7930875)

  • 21. Glomerular permeability: alteration in size- and charge-based barrier function in lupus nephritis.
    Cavallo T
    Ren Physiol; 1980; 3(1-6):250-6. PubMed ID: 7323419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
    Türköz A; Ciğli A; But K; Sezgin N; Türköz R; Gülcan O; Ersoy MO
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):603-10. PubMed ID: 11688002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Established murine lupus nephritis does not respond to exogenous interleukin-1 receptor antagonist; a role for the endogenous molecule?
    Kiberd BA; Stadnyk AW
    Immunopharmacology; 1995 Aug; 30(2):131-7. PubMed ID: 8530254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide.
    Cunnane G; Chan OT; Cassafer G; Brindis S; Kaufman E; Yen TS; Daikh DI
    Arthritis Rheum; 2004 May; 50(5):1539-48. PubMed ID: 15146424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition.
    Rüger BM; Erb KJ; He Y; Lane JM; Davis PF; Hasan Q
    Eur J Immunol; 2000 Sep; 30(9):2698-703. PubMed ID: 11009105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
    Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice.
    Pérez De Lema G; De Wit C; Cohen CD; Nieto E; Molina A; Banas B; Luckow B; Vicente AB; Mampaso F; Schlöndorff D
    J Pharmacol Exp Ther; 2003 Oct; 307(1):275-81. PubMed ID: 12954793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pivotal role of colony stimulating factor-1 in lupus nephritis.
    Rubin Kelley V; Bloom RD; Yui MA; Martin C; Price D
    Kidney Int Suppl; 1994 Feb; 45():S83-5. PubMed ID: 8158905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1997 Dec; 159(11):5610-9. PubMed ID: 9548504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
    J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response.
    Bourbon A; Vionnet M; Leprince P; Vaissier E; Copeland J; McDonagh P; Debré P; Gandjbakhch I
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):932-8. PubMed ID: 15519185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.
    Zavala F; Masson A; Hadaya K; Ezine S; Schneider E; Babin O; Bach JF
    J Immunol; 1999 Nov; 163(9):5125-32. PubMed ID: 10528219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular cytokine expression in murine lupus nephritis.
    Tshilela KA; Ikeuchi H; Matsumoto T; Kuroiwa T; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
    Clin Exp Nephrol; 2016 Feb; 20(1):23-9. PubMed ID: 25985839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The functional and structural changes of the glomerulus throughout the course of murine lupus nephritis.
    Kiberd BA
    J Am Soc Nephrol; 1992 Oct; 3(4):930-9. PubMed ID: 1450369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.